| Expression System | CHO |
|---|
| Protein Tag | No tag |
|---|
| Purity | > 95% by SDS-PAGE under reducing conditions |
|---|
| Endotoxin | < 1 EU per ug by the LAL method |
|---|
| Activity | Positive |
|---|
| Conjugate | Unconjugated |
|---|
| Species | Human |
|---|
| Accession Number | P01574 |
|---|
| Protein Sequence | Met22-Asn187 |
|---|
| Molecular Weight | The protein has a predicted molecular weight of 20 kDa. The protein migrates at approximately 20-25 kDa on SDS-PAGE under reduced condition. |
|---|
| Formulation | Lyophilized powder from 0.22um filtered solution in acetate buffer, pH4.5, 5% trehalose, 5% mannatol, 0.01% tween-80 |
|---|
| Purification | SEC |
|---|
| Applications | ELISA |
|---|
| Format | Lyophilized |
|---|
| Reconstitution | Centrifuge the tube before opening. Recommend reconstitute to a concentration > 100 ug/ml |
|---|
| Shipping Condition | Ambient |
|---|
| Storage/Shelf Life | <-20 °C for 12 months from the date of receipt; -80°C for 3 months after reconstitution. |
|---|
| Background Information | Human Interferon Beta (IFN-beta) is a type I interferon protein that plays a crucial role in the body's immune response, particularly against viral infections. It's primarily produced by fibroblasts and other cells, and it binds to specific receptors on cell surfaces to initiate antiviral states and slow viral replication. IFN-beta also has immunomodulatory effects, helping to regulate the immune system and can be used in the treatment of multiple sclerosis. |
|---|